Form D · Biotechnology

ACCESS BIO, INC.

Somerset, NJ · CIK 0001195790

Offering snapshot reported Nov 20, 2020 · SEC filing

Reported sold: $10M
Investors reported: 1
Minimum accepted: $0
First sale: Nov 17, 2020

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 20, 2020	Initial	$10,000,000	No comparison	1	SEC filing
Apr 6, 2016	Initial	$8,000,000	No comparison	1	SEC filing
May 24, 2011	Initial	$12,000,000	No comparison	1	SEC filing
Mar 30, 2006	Paper	Not reported	No comparison	Not reported

Offering details

Securities: Equity, Security to be acquired, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-381125

US$1,000,000-denominated Convertible Notes due in 2022, including underlying shares of common stock of Issuer issued upon conversion ("Conversion Shares"); 10 note certificates in denomination of USD$1,000,000 in integral multiples

Source: Form D, filed Nov 20, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Seung Jae Baek	Director
Young Ho Choi	Director, Executive
Young Ho Choi	Director, Executive
Sung Oh Chung	Director
Eui Sang Han	Director
Jinsu Jeong	Director
Jaean Jung	Director, Executive
Sang Hoon Kang	Director
Young Ae Kim	Executive
Steven Kwak	Director
Kueun Hyeong Lee	Director
Nam Hyun Ryu	Director
Tom Sabourin	Director
Thomas Sabourin	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

65 Clyde Road Suite A
Somerset, NJ, 08873